Oral ibuprofen promoted cholestatic liver disease in very low birth weight infants with patent ductus arteriosus
{{output}}
Objectives: Hemodynamically significant patent ductus arteriosus (hsPDA) in very low birth weight (VLBW) infants is routinely treated in many countries with oral ibuprofen. This study retrospectively assessed whether the risk of ... ...
